← Eichor
Condition: Synchronous Liver Metastases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Synchronous Liver Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
NA · 1 location(s) · Laval University · NCT06349278
FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07467434
Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases
NA · 1 location(s) · Oslo University Hospital · NCT06200831
Stereotactic Magnetic Resonance Guided Radiation Therapy
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT04115254
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
NA · 13 location(s) · Imperial College London · NCT02246634
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05775146
Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT02886104
Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06787625
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.